In summary, we demonstrated that KLK1‐B1R plays a broad inhibitory role in colorectal tumor formation using two classic colorectal cancer models, the AOM‐DSS inflammation‐oncogenic transformation model and the Apcmin/+ adenoma carcinogenesis model. The gene discussed is KLK1; the disease is colorectal cancer.